1,073 results on '"Lötvall, Jan"'
Search Results
52. Additional file 2 of Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation
53. Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities
54. Rhinitis phenotypes correlate with different symptom presentation and risk factor patterns of asthma
55. Adult-onset asthma in west Sweden – Incidence, sex differences and impact of occupational exposures
56. The duration of bronchodilation of salmeterol and salbutamol as measured by specific airway conductance in healthy subjects
57. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
58. A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles
59. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
60. Sensitization to molecular dog allergens in an adult population: Results from the West Sweden Asthma Study.
61. Sensitization to aeroallergens is dominant in overweight to obese asthmatic males but not in females
62. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy
63. B Cells: From Early Development to Regulating Allergic Diseases
64. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
65. A personality and gender perspective on adherence and health-related quality of life in people with asthma and/or allergic rhinitis
66. Immune-Associated Proteins Are Enriched in Lung Tissue-Derived Extracellular Vesicles during Allergen-Induced Eosinophilic Airway Inflammation
67. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
68. ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19
69. Additional file 1 of Extracellular vesicles from mast cells induce mesenchymal transition in airway epithelial cells
70. Additional file 1 of Decreased COPD prevalence in Sweden after decades of decrease in smoking
71. Additional file 5 of Decreased COPD prevalence in Sweden after decades of decrease in smoking
72. COVID-19 : a very visible pandemic
73. DNA analysis of low- and high-density fractions defines heterogeneous subpopulations of small extracellular vesicles based on their DNA cargo and topology
74. Contributors
75. Comparison of the Bronchodilating Effects of Formoterol and Albuterol Delivered by Hydrofluoroalkane Pressurized Metered-Dose Inhaler
76. The Role of Exosomal Shuttle RNA (esRNA) in Cell-to-Cell Communication
77. Inhaled Combination Therapy with Glucocorticoids and Long-Acting β2-Agonists in Asthma and COPD, Current and Future Perspectives
78. Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomized Trial
79. Pulmonary Inflammation Induced by Bacteria-Free Outer Membrane Vesicles from Pseudomonas aeruginosa
80. Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
81. Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort
82. Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology
83. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology
84. Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methods
85. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial
86. Targeting Drugs to the Airways by Different Inhalation Devices: Role of Deposition Characteristics
87. Local proliferation and mobilization of CCR3+ CD34+ eosinophil-lineage-committed cells in the lung
88. Lung Regulatory T Cells Express Adiponectin Receptor 1: Modulation by Obesity and Airway Allergic Inflammation
89. 818 Synergistic cancer immunotherapy using tumor tissue-derived exosomes and artificially produced bacterial outer membrane vesicles
90. Growing up on a farm and multi-symptom asthma in adults >50 years by age of asthma onset
91. Abstract LB-095: Synergistic cancer immunotherapy using tumor tissue derived exosomes and artificially produced bacterial outer membrane vesicles
92. COVID-19—a very visible pandemic
93. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation
94. Asthma in late adolescence – farm childhood is protective and the prevalence increase has levelled off
95. Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium
96. Eosinophil progenitors in allergy and asthma — Do they matter?
97. The effect of formoterol over 24 h in patients with asthma: the role of enantiomers
98. Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD
99. Additional file 1: of Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10
100. Salmeterol: An inhaled /β2-agonist with prolonged duration of action
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.